These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28939617)

  • 1. J Curve in Patients Randomly Assigned to Different Systolic Blood Pressure Targets: An Experimental Approach to an Observational Paradigm.
    Kalkman DN; Brouwer TF; Vehmeijer JT; Berger WR; Knops RE; de Winter RJ; Peters RJ; van den Born BH
    Circulation; 2017 Dec; 136(23):2220-2229. PubMed ID: 28939617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
    Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
    Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control.
    Beddhu S; Chertow GM; Cheung AK; Cushman WC; Rahman M; Greene T; Wei G; Campbell RC; Conroy M; Freedman BI; Haley W; Horwitz E; Kitzman D; Lash J; Papademetriou V; Pisoni R; Riessen E; Rosendorff C; Watnick SG; Whittle J; Whelton PK;
    Circulation; 2018 Jan; 137(2):134-143. PubMed ID: 29021322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Blood Pressure Measurements With Peripheral Artery Disease Events.
    Itoga NK; Tawfik DS; Lee CK; Maruyama S; Leeper NJ; Chang TI
    Circulation; 2018 Oct; 138(17):1805-1814. PubMed ID: 29930023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.
    Kario K; Iwashita M; Okuda Y; Sugiyama M; Saito I; Kushiro T; Teramukai S; Shimada K
    Hypertension; 2018 Oct; 72(4):854-861. PubMed ID: 30354719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Hypertension; 2017 Dec; 70(6):1273-1282. PubMed ID: 29038204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remnant cholesterol and intensive blood pressure control in older patients with hypertension: a post hoc analysis of the STEP randomized trial†.
    Yang R; Zhang J; Yu X; Yang G; Cai J
    Eur J Prev Cardiol; 2024 Jun; 31(8):997-1004. PubMed ID: 38167928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
    Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
    Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.
    Bundy JD; Li C; Stuchlik P; Bu X; Kelly TN; Mills KT; He H; Chen J; Whelton PK; He J
    JAMA Cardiol; 2017 Jul; 2(7):775-781. PubMed ID: 28564682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving target SBP for lowering the risk of major adverse cardiovascular events in persons with diabetes mellitus.
    Ó Hartaigh B; Szymonifka J; Okin PM
    J Hypertens; 2018 Jan; 36(1):101-109. PubMed ID: 28832365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
    Still CH; Rodriguez CJ; Wright JT; Craven TE; Bress AP; Chertow GM; Whelton PK; Whittle JC; Freedman BI; Johnson KC; Foy CG; He J; Kostis JB; Lash JP; Pedley CF; Pisoni R; Powell JR; Wall BM;
    Am J Hypertens; 2017 Dec; 31(1):97-107. PubMed ID: 28985268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.
    Navar AM; Gallup DS; Lokhnygina Y; Green JB; McGuire DK; Armstrong PW; Buse JB; Engel SS; Lachin JM; Standl E; Van de Werf F; Holman RR; Peterson ED;
    Hypertension; 2017 Nov; 70(5):907-914. PubMed ID: 28847886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
    Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
    J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.